title: Interstitial lung disease arising from erlotinib treatment in a Caucasian patient.
authors.affiliation: Catalan Institute of Oncology-Badalona, Barcelona, Spain. Electronic address: cbuges@iconcologia.net.
authors.forename: Cristina
authors.initials: C
authors.lastname: Bugés
authors.affiliation: Catalan Institute of Oncology-Badalona, Barcelona, Spain.
authors.forename: Enric
authors.initials: E
authors.lastname: Carcereny
authors.affiliation: Catalan Institute of Oncology-Badalona, Barcelona, Spain.
authors.forename: Teresa
authors.initials: T
authors.lastname: Moran
authors.affiliation: Clinical and Translational Oncology Group, Instituto de Oncología, Fundación Santa Fe de Bogotá, Colombia.
authors.forename: Andrés Felipe
authors.initials: AF
authors.lastname: Cardona
authors.affiliation: Hospital Clínic de Barcelona, Barcelona, Spain.
authors.forename: Noemi
authors.initials: N
authors.lastname: Reguart
authors.affiliation: Hospital de Sant Pau i Santa Tecla, Tarragona, Spain.
authors.forename: Laia
authors.initials: L
authors.lastname: Capdevila
authors.affiliation: Hospital General de Granollers, Barcelona, Spain.
authors.forename: Sara
authors.initials: S
authors.lastname: Cros
authors.affiliation: Catalan Institute of Oncology-Badalona, Barcelona, Spain.
authors.forename: Rafael
authors.initials: R
authors.lastname: Rosell
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D044465:White People
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors
keywords: Corticosteroids; Erlotinib; Interstitial lung disease; Lung toxicity; TKI